Listing 1 - 10 of 26 | << page >> |
Sort by
|
Choose an application
Epstein-Barr virus (EBV) is a fascinating microorganism, as a "double-facetted" viral agent. After primary infection, it can persist throughout a person's lifetime in a latent form, from which it can reactivate following specific stimuli (i.e., immunodepression). Unlike other herpesviruses, EBV reactivates a countless number of times with such a high replication rate that it is unable to be controlled by conventional anti-herpesvirus drugs. Moreover, for various reasons, no vaccine is currently available in the market. This book presents a comprehensive overview of EBV, including information on its potential for oncogenic activity, its various isolates, and possible vaccine candidates.
Choose an application
Epstein-Barr virus (EBV) is a ubiquitous virus that infects 95% of adults worldwide; the vast majority of persons have asymptomatic or non-specific primary infection and no complications associated with EBV during their lifetime. Some persons, particularly those who are infected as adolescents or young adults, develop infectious mononucleosis. EBV infects resting B cells and infection in vitro results in transformation and continuous proliferation of the cells, whereas infection in vivo results in a latent infection in which proliferation of the cells is controlled by virus-specific T cells and NK cells. Certain persons have mutations in genes that result in impaired cellular immunity involving the function of cytotoxic T cells or NK cells that result in impaired responses and failure to control EBV. These persons are at risk for fulminant infectious mononucleosis, EBV-associated hemophagocytosis, EBV B or T cell lymphoma, or other opportunistic infections. These genes encode proteins that are important for a variety of NK and T cell activities: T cell interactions with B cells, NK and T cell activation, NK and T cell cytotoxicity, priming and expansion of virus-specific T cells, and control of T cell apoptosis. For most of these diseases, hematopoietic stem cell transplantation has been the only curative therapy. However, identification of certain immune deficiencies has led to new approaches to therapy such as drugs to inhibit overactive signaling pathways or supplemental magnesium for patients with mutations in a magnesium transporter. The study of these EBV-associated immune deficiencies identifies the importance of these proteins for the function of T and NK cells and may lead to novel approaches to therapy for EBV diseases.
Epstein-Barr virus --- immune deficiency --- lymphoproliferative disease --- hemophagocytic lymphohistiocytosis --- B-cell lymphoma
Choose an application
Annotation
Oncogenic viruses. --- Tumors --- Virus diseases. --- Epstein-Barr virus diseases. --- Kaposi's sarcoma. --- Papillomaviruses. --- Virology.
Choose an application
Fatigue is quite a familiar sensation, one that everyone is likely to have experienced. Its molecular and neural mechanisms have not yet been elucidated, however, probably because of the complicated nature of its causes. To provide a broad forum for discussion, the International Conference on Fatigue Science was organized, the first being held in 2002 in Sandhamn, Sweden, and the second in 2005 in Karuizawa, Japan. Subsequently it was decided that the papers presented at the two conferences should be collected and incorporated in this pioneering work, Fatigue Science for Human Health. The book summarizes fatigue researchers' achievements, explains the status of the research on fatigue, and presents perspectives on remedies for chronic fatigue and chronic fatigue syndrome. The result is an authoritative guide to recent progress in the molecular and neural mechanisms of fatigue and in the development of the ways to prevent and overcome fatigue and chronic fatigue. This book provides a valuable resource not only for physicians but for all who work in public health.
Fatigue --- Chronic fatigue syndrome --- Chronic fatigue and immune dysfunction syndrome --- Chronic fatigue immune dysfunction syndrome --- Diseases --- Syndromes --- Epstein-Barr virus diseases --- Exhaustion --- Lassitude --- Tiredness --- Weariness --- Physiology --- Symptoms --- Rest
Choose an application
While the chapters in this book are a long way from solving the enigma that is CFS, they do represent important attempts to understand this complex and perplexing disease. A common theme in them all is CFS as a multisystem disease with the possibility of more than one cause and influenced by a variety of interacting factors. Further, they acknowledge the reality of CFS for persons with this disease and the importance of finding causes, treatments and ultimately a cure. As advanced biomedical research techniques are increasingly applied to the study of CFS, it is surely only a matter of time before biomarkers are identified, etiologies understood, and remedies devised.
Chronic fatigue syndrome. --- Chronic fatigue and immune dysfunction syndrome --- Chronic fatigue immune dysfunction syndrome --- Diseases --- Fatigue --- Syndromes --- Epstein-Barr virus diseases --- Psychiatry
Choose an application
Chronic fatigue syndrome --- Chronic fatigue and immune dysfunction syndrome --- Chronic fatigue immune dysfunction syndrome --- Diseases --- Fatigue --- Syndromes --- Epstein-Barr virus diseases --- Patients --- King, Roger,
Choose an application
Chronic Fatigue Syndrome (CFS) or Myalgic Encephalomyelitis (ME) has no clear aetiology, and is defined as severe and chronic fatigue that has lasted for more than six consecutive months, which is not due to physical exertion or other medical conditions associated with fatigue. CFS patients may suffer from four or more of the following symptoms: post-exertional malaise lasting for more than 24 hours; tender or swollen lymph nodes; recurring sore throat; unrefreshing sleep; significantly impaired short-term memory and/or concentration; headaches; or joint pain. Management practices have include
Choose an application
This Special Issue on CFS/ME collects 18 papers with an interdisciplinary view on the current demographic and epidemiological data and immunological characteristics of CFS/ME and examines the different pathogenic hypotheses, as well as giving information about the latest knowledge on diagnostic investigations, pharmacological, integrative, physical, cognitive-behavioral and psychological curative approaches.
Choose an application
Epstein Barr virus (EBV) was discovered as the first human tumor virus around 50 years ago. Since its discovery in Burkitt’s lymphoma it has been associated with various other malignancies, infectious mononucleosis and even autoimmune diseases. The two book volumes on EBV summarize the first 50 years of research on this tumor virus, starting with historical perspectives on discovery, oncogenicity and immune control, reviewing the role that the virus plays in the various associated diseases and concluding with a discussion on how the immune system keeps persistent EBV infection under control in healthy EBV carriers and can be used to treat EBV associated diseases. The respective 32 chapters are written by international experts from three continents for health care providers, biomedical researchers and patients that are affected by EBV. The assembled knowledge should help to understand EBV associated diseases better and to develop EBV specific vaccination in the near future.
Microbiology & Immunology --- Biology --- Health & Biological Sciences --- Epstein-Barr virus. --- Epstein-Barr virus diseases. --- EBV diseases --- Burkitt herpesvirus --- Burkitt's lymphoma virus --- E-B virus --- EBV (Virus) --- Human herpesvirus-4 --- Infectious mononucleosis virus --- Medicine. --- Virology. --- Biomedicine. --- Microbiology --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Physicians --- Herpesvirus diseases --- Chronic fatigue syndrome --- Herpesviruses --- Oncogenic DNA viruses --- Medical virology. --- Medical microbiology --- Virology --- Virus diseases
Choose an application
This SpringerBrief is comprehensive account of the functions and effects of the Epstein-Barr virus (EBV) EBNA1 protein that relate to EBV-associated cancers and evidence for EBNA1 contributions to these cancers. EBNA1 was the first EBV protein detected and the most critical for EBV latent infection. EBNA1 fulfills multiple functions at EBV genomes which have been described in many (sometimes confusing) reports over the last 28 years. While these were initially thought to be the only roles of EBNA1, many reports in recent years have shown that EBNA1 also directly affects cellular processes in ways that would be expected to contribute to oncogenesis. However, the degree to which EBNA1 promotes cell survival and oncogenesis in various types of human tumours is not entirely clear and a matter of debate. This book offers a current synopsis of EBNA1 functions in EBV latency, including functions in DNA replication, mitotic segregation and transcription. Mechanisms of these EBNA1 functions is also discussed as well as implications for tumourigenesis. In addition, the cellular effects of EBNA1 will be reviewed, including how EBNA1 manipulates specific cellular proteins and relationships to EBV-associated lymphomas and carcinomas.
Carcinogenesis. --- Cell transformation, Neoplastic. --- Herpesvirus 4, Human. --- Epstein-Barr virus diseases --- Biology --- Antigens, Nuclear --- Lymphocryptovirus --- Antigens --- Gammaherpesvirinae --- Biological Science Disciplines --- Biological Factors --- Natural Science Disciplines --- Herpesviridae --- DNA Viruses --- Chemicals and Drugs --- Disciplines and Occupations --- Viruses --- Organisms --- Epstein-Barr Virus Nuclear Antigens --- Herpesvirus 4, Human --- Genetics --- Medicine --- Health & Biological Sciences --- Oncology --- Epstein-Barr virus diseases. --- Cancer. --- Cancers --- Carcinoma --- Malignancy (Cancer) --- Malignant tumors --- EBV diseases --- Medicine. --- Cancer research. --- Medical microbiology. --- Virology. --- Biomedicine. --- Cancer Research. --- Medical Microbiology. --- Tumors --- Herpesvirus diseases --- Chronic fatigue syndrome --- Oncology. --- Medical virology. --- Microbiology. --- Microbial biology --- Microorganisms --- Medical microbiology --- Virology --- Virus diseases --- Microbiology --- Cancer research
Listing 1 - 10 of 26 | << page >> |
Sort by
|